Company Overview

Business Description

Headquarters
Canada CA
IPO date
Jul 18, 2022

PanGenomic Health, Inc. operates as a health care platform company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-07-18. The firm has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support a user's specific health needs. The company has developed a health-tech platform to provide further personal control over mental health treatments. Its personalized insight system helps individuals and healthcare practitioners connect with precision natural remedy mental wellness options. Its mobile application, the Nara App, provides consumers with a knowledge base, which is based on an individual's user profile, developed by tracking treatment regimen and their multidimensional biomarkers (gene, protein, metabolite, microbiota). Its digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to the consumer's Nara App data and their diagnostic reports to improve identification of appropriate natural remedy treatments. Mindleap Health Inc. is its subsidiary.

Pangenomic Health Inc Investor Relations

Address
3800 Wesbrook Mall, Suite 102
Vancouver, British Columbia
Canada

Management

Mr. Robert Carl Nygren

Co-Founder & Executive Chairman

Biography unavailable

Ms. Maryam Marissen

CEO, President & Director

Biography unavailable

Mr. Vincent L. Lum

Co-Founder

Biography unavailable

Ms. Tammy Gillis C.M.A., CPA, CMA, CPA

CFO, Treasurer & Secretary

Biography unavailable

Mr. Derek Ho

Director of Operations

Biography unavailable

Mr. Kaidong Zhang

Chief Scientific Officer

Biography unavailable

Mr. Colin Quon

Chief Technology Officer of MUJN Diagnostics

Biography unavailable

1 / 7